The West already monopolized scientific publishing. Covid made it worse.


Samanth Subramanian at Quartz: “For nearly a decade, Jorge Contreras has been railing against the broken system of scientific publishing. Academic journals are dominated by the Western scientists, who not only fill their pages but also work for institutions that can afford the hefty subscription fees to these journals. “These issues have been brewing for decades,” said Contreras, a professor at the University of Utah’s College of Law who specializes in intellectual property in the sciences. “The covid crisis has certainly exacerbated things, though.”

The coronavirus pandemic triggered a torrent of academic papers. By August 2021, at least 210,000 new papers on covid-19 had been published, according to a Royal Society study. Of the 720,000-odd authors of these papers, nearly 270,000 were from the US, the UK, Italy or Spain.

These papers carry research forward, of course—but they also advance their authors’ careers, and earn them grants and patents. But many of these papers are often based on data gathered in the global south, by scientists who perhaps don’t have the resources to expand on their research and publish. Such scientists aren’t always credited in the papers their data give rise to; to make things worse, the papers appear in journals that are out of the financial reach of these scientists and their institutes.

These imbalances have, as Contreras said, been a part of the publishing landscape for years. (And it doesn’t occur just in the sciences; economists from the US or the UK, for instance, tend to study countries where English is the most common language.) But the pace and pressures of covid-19 have rendered these iniquities especially stark.

Scientists have paid to publish their covid-19 research—sometimes as much as $5,200 per article. Subscriber-only journals maintain their high fees, running into thousands of dollars a year; in 2020, the Dutch publishing house Elsevier, which puts out journals such as Cell and Gene, reported a profit of nearly $1 billion, at a margin higher than that of Apple or Amazon. And Western scientists are pressing to keep data out of GISAID, a genome database that compels users to acknowledge or collaborate with anyone who deposits the data…(More)”